Lacosamide Impurity 17 | CAS 1253790-58-7 - Request Quote
Lacosamide Impurity 17
| SZ CAT No: | SZ-L033044 |
| CAS No | 1253790-58-7 |
| Mol.F. | C15H22N2O4 |
| Mol.Wt. | 294.4 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lacosamide Impurity 17 is chemically Tert-butyl (R)-(1-(benzylamino)-3-hydroxy-1-oxopropan-2-yl)carbamate. Lacosamide Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Lacosamide Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lacosamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1253790-58-7
Purchase 1253790-58-7
Order 1253790-58-7
Enquire 1253790-58-7
price of 1253790-58-7
1253790-58-7 Supplier
1253790-58-7 Manufacturer
1253790-58-7 Exporter
buy high quality Lacosamide Impurity 17
Purchase Lacosamide Impurity 17
Lacosamide Impurity 17 suppliers
Lacosamide Impurity 17 manufacturers
Lacosamide Impurity 17 price
Order Lacosamide Impurity 17
Enquire Lacosamide Impurity 17
Lacosamide Impurity 17 cost
Lacosamide Impurity 17 Supplier
Lacosamide Impurity 17 Distributor
Lacosamide Impurity 17 for Method Validation
Lacosamide Reference Standard
Lacosamide Impurity 17 for ANDA Filing
Lacosamide Impurity 17 for Forced Degradation Studies
Lacosamide Impurity 17 Identification Standards
Lacosamide Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


